• Explore /
  • Poster
  • / NIVES study: A phase II trial of nivolumab (NIVO) plus stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC).

NIVES study: A phase II trial of nivolumab (NIVO) plus stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC).

Abstract Poster

Authors

null

Cristina Masini

Medical Oncology Unit, Clinical Cancer Center, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy

Cristina Masini , Cinzia Iotti , Patrizia Ciammella , Roberta Gnoni , Annalisa Berselli , Maria Giuseppa Vitale , Ugo De Giorgi , Claudia Mucciarini , Sebastiano Buti , Giuseppe Procopio , Roberto Iacovelli , Giorgio V. Scagliotti , Sergio Bracarda , Orazio Caffo , Franco Morelli , Carmelo Bengala , Franco Nole , Susanne Baier , Stefano Panni , Carmine Pinto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

EudraCT Number 2016-003032-20

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS4602)

DOI

10.1200/JCO.2018.36.15_suppl.TPS4602

Abstract #

TPS4602

Poster Bd #

420a

Abstract Disclosures

Similar Posters

First Author: Jing Liu

First Author: Deirdre Jill Cohen

First Author: Suzanne Phillips

First Author: Gustavo Schvartsman